Review of PROTAC – a drug that may alter the future of cancer therapy
By: Yeonah Suk, PharmD Candidate c/o 2020 - Despite the $107 billion a year cancer drug industry there is no…
Pharmacists’ role in flu emergencies
By: Yao Jiang, PharmD Candidate c/o 2019 - While each flu season comes and goes, the 2017-2018 flu season caught…
An overview of “leadership” in pharmacy education
By: Shivani Shah, PharmD Candidate c/o 2021 and Jagannath Muzumdar, PhD Associate Professor Pharmacy - Pharmacy Administration and Public Health…
2018 ACC/AHA new hypertension guidelines review
By: Gabrielle Flavoni, PharmD Candidate c/o 2018 - This past November, the ACC/AHA released a new definition for the word…
Pharmacotherapy in posttraumatic stress disorder and the link to increased dementia risk
By: Michelle Huang, PharmD Candidate c/o 2021 - In the midst of countless chronic diseases that we face today, one…
Review on the use of hydroxyurea – 50 years of FDA approval
By: Jonathan Mercado, PharmD Candidate c/o 2019 - Hydroxyurea is a versatile, multi-functional drug that has been used for decades…
You vs. diabetes
By: Gabriel Ilyayev, PharmD Candidate c/o 2018 - My grandpa is a type 2 diabetic. My father is a type…
CDC and pharmacists fight antibiotic resistance
By: Katharine Russo, PharmD Candidate c/o 2021 - With the continued increase of antibiotic resistant diseases, scientists are calling this…
Safety and efficacy of a new drug: sofosbuvir/velpatasvir/voxilaprevir (Vosevi®)
By: Shireen Farzadeh, PharmD Candidate c/o 2019 - Sofosbuvir/velpatasvir/voxilaprevir (Vosevi®) is the first pangenotypic fixed-dose combination tablet that includes 400…
The opioid epidemic: a national crisis
By: Katharine Russo, PharmD Candidate c/o 2021 - The DEA announced in August 2017 that 2018 would bring strict manufacturing…